Rationale: This is a rare case of mediastinal typical carcinoid tumor with elevated parathyroid hormone (PTH) and hypercalcemia detected by 99m Tc -methoxy-isobutyl-isonitrile( 99m Tc-MIBI) single photon emission computed tomography/computed tomography (SPECT/CT) imaging.
Introduction
Carcinoid is a rare well-differentiated tumor that origins from amine precursor uptake decarboxylation (APUD) cell system. [1, 2] Typical and atypical carcinoid tumors are distinguished on the basis of morphology, mitosis count, and the presence or absence of necrosis. [3, 4] Typical carcinoid has a less aggressive behavior; it rarely relapses after complete surgical resection, and nodal involvement and distant metastases are rare. [5, 6] Carcinoids occur most frequently (90% of cases) in the gastrointestinal tract. [6] The second most common location is the respiratory tract ( Figs. 1 and 2 ).
Other anatomic locations are extremely rare. [7, 8] There were less reports about mediastinal carcinoid. [9] Here, we report a rare case of mediastinal typical carcinoid tumor in a patient with elevated parathyroid hormone (PTH) and hypercalcemia.
Case report
A 65-year-old man complained about increased foam in urine. 
Discussion
We report a rare case of mediastinal typical carcinoid tumor in a patient with elevated PTH and hypercalcemia. The mechanism of the elevation of PTH and hypercalcemia may be as follows: As carcinoid tumors originate in the cells of APUD system, they can express different peptides and biogenic amines, [1] such as 5-hydroxytryptamine (5-HT),bradykinin, adrenocorticotropic hormone, thus causing carcinoid syndrome, ectopic adrenocorticotropic hormone (ACTH) syndrome. [3] In this case,no tumor was detected on the parathyroid gland. And when the mediastinal lesion was removed, there was a dramatic decline of iPTH. Then, we could infer that the carcinoid tumor could secrete PTH, which is a low molecular polypeptide, leading to secondary hypercalcemia. Besides, the patient suffered from chronic renal insufficiency, which caused disorder of calcium and phosphate metabolism and secondarily elevated iPTH.
However, after removal of offending tumor in mediastinum, iPTH level was high even after 4 weeks of surgery, albeit, serum calcium level had normalized. This may be because the function of parathyroid was inhibited by the mediastinal mass. So, when the mass was removed, reflexively elevated PTH secreted by parathyroid appeared. Furthermore, the patient was still not recovered from chronic renal insufficiency, which also made a contribution to abnormal PTH level.
Cases about mediastinal carcinoid detected by 99m Tc-MIBI scintigraphy were scarcely reported. Several 99m Tc-MIBI uptake mechanisms are thought to contribute to its accumulation in the carcinoid. On the one hand, it is thought to be due to an increased vascularity and vascular permeability at the site of tumor. On the other hand, it could go back to the chemical characteristics of radiopharmaceuticals, the cationic charge, the lipophilic properties, and the negative transmembrane potentials generated in the cytoplasm and mitochondria of metabolically active cells. [10] Carcinoid tumors pose a diagnostic challenge and many are found during surgery. In this case, the most common differential diagnosis will be ectopic parathyroid adenoma. [11] The exact diagnosis between mediastinal carcinoid with elevated PTH and ectopic parathyroid adenoma depends on pathology. For another, MEN type I could also present with high PTH level. However, there was no evidence to diagnose MEN type I because no abnormity was showed in parathyroid, pancreas, and pituitary according to laboratory tests, imageological examinations, and history. [4] Finally, the deficiency of this paper was that immunostaining did not show whether the resected specimen was positive for PTH. We can infer that the carcinoid tumor secretes PTH by the sharp decline of PTH level after removal of the mediastinal mass.
